Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 2
2017 3
2018 1
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis.
Chekol SS, Sun CC. Chekol SS, et al. Arch Pathol Lab Med. 2012 Jan;136(1):113-7. doi: 10.5858/arpa.2010-0550-RS. Arch Pathol Lab Med. 2012. PMID: 22208496 Free article. Review.
Malignant mesothelioma of the tunica vaginalis testis is an extremely rare tumor representing 0.3% to 5% of all malignant mesotheliomas. Gross examination of testicular mesotheliomas typically reveals tumor nodules studding the thickened tunica vaginalis and, in som …
Malignant mesothelioma of the tunica vaginalis testis is an extremely rare tumor representing 0.3% to 5% of all malignant mesotheliom …
STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer.
Wang Y, Trepel JB, Neckers LM, Giaccone G. Wang Y, et al. Curr Opin Investig Drugs. 2010 Dec;11(12):1466-76. Curr Opin Investig Drugs. 2010. PMID: 21154128 Review.
STA-9090 binds to the ATP-binding domain at the N-terminus of Hsp90 and acts as a potent Hsp90 inhibitor by inducing degradation of multiple oncogenic Hsp90 client proteins including HER2/neu, mutated EGFR, Akt, c-Kit, IGF-1R, PDGFRalpha, Jak1, Jak2, STAT3, STAT5, HIF-1alpha, CDC …
STA-9090 binds to the ATP-binding domain at the N-terminus of Hsp90 and acts as a potent Hsp90 inhibitor by inducing degradation of multiple …
Clinical Utility of Wilms' Tumor 1 Monitoring in Patients with Myeloid Malignancy and Prior Allogeneic Hematopoietic Stem Cell Transplantation.
Ino K, Fuji S, Tajima K, Tanaka T, Okinaka K, Inamoto Y, Kurosawa S, Kim SW, Katayama N, Fukuda T. Ino K, et al. Biol Blood Marrow Transplant. 2017 Oct;23(10):1780-1787. doi: 10.1016/j.bbmt.2017.06.007. Epub 2017 Jun 30. Biol Blood Marrow Transplant. 2017. PMID: 28673850 Free article.
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is 1 of the standard treatments for myeloid malignancy, relapse remains a major obstacle to cure. Early detection of relapse by monitoring of minimal residual disease (MRD) may enable us to intervene p …
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is 1 of the standard treatments for myeloid malignancy, relap …
Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
Yamauchi T, Negoro E, Lee S, Takai M, Matsuda Y, Takagi K, Kishi S, Tai K, Hosono N, Tasaki T, Ikegaya S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Yamauchi T, et al. Anticancer Res. 2013 Aug;33(8):3335-40. Anticancer Res. 2013. PMID: 23898100
BACKGROUND/AIM: The present retrospective study was conducted to measure Wilms' tumor-1 (WT1) mRNA levels in the peripheral blood of patients with acute myeloid leukemia (AML) in order to examine any association with the clinical outcomes. ...
BACKGROUND/AIM: The present retrospective study was conducted to measure Wilms' tumor-1 (WT1) mRNA levels in the periph …
Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors.
Uehara S, Oue T, Nakahata K, Nara K, Ueno T, Owari M, Usui N, Miyamura T, Hashii Y. Uehara S, et al. Eur J Pediatr Surg. 2015 Feb;25(1):118-22. doi: 10.1055/s-0034-1386638. Epub 2014 Aug 11. Eur J Pediatr Surg. 2015. PMID: 25111275
PATIENTS AND METHODS: We retrospectively reviewed the cases of 24 children with advanced malignancy treated with HDC and HSCT before tumor resection at our institution. The tumors included 18 neuroblastomas, 5 soft tissue sarcomas, 2 hepatoblastomas, and 1 Wilms …
PATIENTS AND METHODS: We retrospectively reviewed the cases of 24 children with advanced malignancy treated with HDC and HSCT before tumo …
Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H, Dikme G, Özdemir N, Kuruğoğlu S, Adaletli İ, Erkan T, Celkan T. Kizilocak H, et al. J Pediatr Hematol Oncol. 2017 Oct;39(7):e373-e376. doi: 10.1097/MPH.0000000000000958. J Pediatr Hematol Oncol. 2017. PMID: 28859028
Between the year 1995 and 2016, 414 patients were diagnosed with acute lymphoblastic leukemia and 113 patients were diagnosed with Wilms tumor in our institution. Among these patients, 4 patients with acute lymphoblastic leukemia (0.96%) and 2 patients with Wilms …
Between the year 1995 and 2016, 414 patients were diagnosed with acute lymphoblastic leukemia and 113 patients were diagnosed with Wilms …
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma.
Kambara T, Amatya VJ, Kushitani K, Suzuki R, Fujii Y, Kai Y, Miyata Y, Okada M, Takeshima Y. Kambara T, et al. Am J Surg Pathol. 2020 Sep;44(9):1259-1265. doi: 10.1097/PAS.0000000000001507. Am J Surg Pathol. 2020. PMID: 32496433
SOX6 expression showed similar sensitivity and far better specificity than those of calretinin or podoplanin (D2-40). In addition, SOX6 expression was more sensitive than Wilms' tumor 1 expression. The combination of SOX6 with other markers showed comparable …
SOX6 expression showed similar sensitivity and far better specificity than those of calretinin or podoplanin (D2-40). In addition, SOX6 expr …
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes.
Harada S, Onozawa M, Hidaka D, Yokoyama S, Senjo H, Takahashi S, Ogasawara R, Kanaya M, Mori A, Ota S, Kondo T, Teshima T. Harada S, et al. Ann Hematol. 2022 Jun;101(6):1239-1250. doi: 10.1007/s00277-022-04807-w. Epub 2022 Mar 8. Ann Hematol. 2022. PMID: 35257209
To elucidate whether dynamic change in peripheral blood (PB) Wilms' Tumor 1 (WT1) mRNA levels could predict response to AZA, we retrospectively identified 75 treatment-naive patients with high-risk MDS who received at least 3 cycles of AZA. ...Multivariate an …
To elucidate whether dynamic change in peripheral blood (PB) Wilms' Tumor 1 (WT1) mRNA levels could predict response to …
Genetic mutational testing of Chinese children with familial hematuria with biopsy-proven FSGS.
Li Y, Wang Y, He Q, Dang X, Cao Y, Wu X, Mo S, He X, Yi Z. Li Y, et al. Mol Med Rep. 2018 Jan;17(1):1513-1526. doi: 10.3892/mmr.2017.8023. Epub 2017 Nov 10. Mol Med Rep. 2018. PMID: 29138824 Free PMC article.
Genomic DNA of the siblings affected by FH with biopsy-proven FSGS was analyzed, and their father was screened for 18 gene mutations associated with FSGS [nephrin, podocin, CD2 associated protein, phospholipase C epsilon, actinin alpha 4, transient receptor potential cation chann …
Genomic DNA of the siblings affected by FH with biopsy-proven FSGS was analyzed, and their father was screened for 18 gene mutations associa …
Epigenotype, genotype, and phenotype analysis of patients in Taiwan with Beckwith-Wiedemann syndrome.
Lin HY, Chuang CK, Tu RY, Fang YY, Su YN, Chen CP, Chang CY, Liu HC, Chu TH, Niu DM, Lin SP. Lin HY, et al. Mol Genet Metab. 2016 Sep;119(1-2):8-13. doi: 10.1016/j.ymgme.2016.07.003. Epub 2016 Jul 12. Mol Genet Metab. 2016. PMID: 27436784
RESULTS: Twenty-eight patients received a clinical diagnosis of BWS (the presence of 3 major features or 2 major features and at least 1 minor feature), 18 had suspected BWS (the presence of at least 1 major feature), and 1 had isolated Wilms' tumor …
RESULTS: Twenty-eight patients received a clinical diagnosis of BWS (the presence of 3 major features or 2 major features and at least 1 …
15 results